April 01, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, is providing this reminder that data from the Company ...

Microbot Medical (NASDAQ:MBOT – Get Free Report) is projected to issue its quarterly earnings data before the market opens on Wednesday, March 26th. Analysts expect the company to announce earnings of ...

Microbot Medical Inc. (NASDAQ:MBOT – Get Free Report)’s stock price crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving ...

The put/call ratio of MBOT is 0.03, indicating a bullish outlook. What are Other Shareholders Doing? Armistice Capital holds 300K shares representing 2.08% ownership of the company. In it's prior ...

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

Stay updated on market trends for MBOT. Microbot Medical shares are trading higher by 33% during Monday's session. The company is raising $7 million through stock sales and investment options.

Short interest is currently not available. Nasdaq provides information of company’s short interest and the average days it takes to cover them. Short interest and days to cover can be used to ...